Trends in Perioperative Magnesium Sulfate Use in Patients Who Underwent Major Cancer Surgery: A Retrospective Population-Based Cohort Study in South Korea.
In-Ae SongTak Kyu OhSang-Hwan DoPublished in: Cancer control : journal of the Moffitt Cancer Center (2023)
In South Korea, 6.6% of the patients who underwent major cancer surgery were administered magnesium sulfate during surgery. Certain factors, such as old age, thoracic cancer surgery, open laparotomy or thoracotomy, greater comorbid status, and inhalation anesthesia, were potentially associated with magnesium sulfate administration in patients undergoing major cancer surgery.
Keyphrases
- minimally invasive
- papillary thyroid
- coronary artery bypass
- patients undergoing
- surgical site infection
- squamous cell
- newly diagnosed
- end stage renal disease
- ejection fraction
- prognostic factors
- lymph node metastasis
- spinal cord injury
- squamous cell carcinoma
- acute coronary syndrome
- percutaneous coronary intervention
- spinal cord
- acute kidney injury
- aortic valve
- coronary artery disease
- aortic stenosis
- childhood cancer